Impeding transcription of expanded microsatellite repeats using deactivated Cas9
使用失活的 Cas9 阻止扩展微卫星重复序列的转录
基本信息
- 批准号:10570973
- 负责人:
- 金额:$ 37.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-15 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAmyotrophic Lateral SclerosisAnimal Disease ModelsAnimal ModelAntisense OligonucleotidesAutomobile DrivingBacterial Artificial ChromosomesC9ORF72CUG repeatCell NucleusCell modelCellsCentral Nervous SystemCessation of lifeCharacteristicsComplexCorneal EndotheliumCorneal dystrophyCytoplasmDNADactinomycinDataDefectDependovirusDiseaseDoseElementsEnzymesEpisomeExhibitsFiberGaitGeneticGenetic TranscriptionGenomeGuide RNAHeartHumanHuman CharacteristicsHuntington DiseaseInduced pluripotent stem cell derived neuronsInheritedLengthMethodsMicrosatellite RepeatsModelingMolecularMotor NeuronsMuscleMuscle FibersMyotoniaMyotonic DystrophyMyotonic dystrophy type 1NuclearNuclear ExportNuclear ImportParalysedPathogenicityPathologicPathologyPatternPeptidesPhenotypePhysiologicalPlayProductionProteinsPublishingRNARNA Polymerase IIRNA ProcessingRNA SplicingRNA-Binding ProteinsRepetitive SequenceSymptomsTestingTherapeuticTherapeutic InterventionTissuesToxic effectTranscriptTransgenic MiceTransgenic ModelTranslationsTravelViralcell typecofactordisease phenotypeepigenetic silencingexperimental studyfrontotemporal lobar dementia amyotrophic lateral sclerosisgain of functionhuman diseaseimprovedknock-downloss of functionmanufacturing runmotor neuron degenerationmouse modelnanomolarneuron lossneurotoxicityprematurerecruitsmall moleculetherapeutically effectivetooltranscriptome
项目摘要
Transcription of expanded microsatellite repeats is associated with a number of human diseases, including
myotonic dystrophy (DM), Fuch's endothelial corneal dystrophy, and C9orf72 ALS/FTD (C9ALS/FTD), among
others. Eliminating or reducing production of RNA and proteins arising from these expanded loci holds
therapeutic benefit. Here, we will test the hypothesis that a deactivated form of the Cas9 enzyme impedes
transcription across expanded microsatellite repeats, in cell and animal models of DM and C9ALS/FTD. We
have previously observed a repeat length-, PAM-, and strand-dependent reduction in the abundance of repeat-
containing RNAs upon targeting dCas9 directly to repeat sequences. Aberrant Muscleblind-dependent splicing
patterns were rescued in DM1 cells, and production of RAN peptides characteristic of C9orf72 ALS/FTD cells
was drastically decreased. Pathological CUG-containing RNA foci in DM1 mouse model muscle fibers was
reduced by dCas9/gRNA delivered by adeno-associated virus. These observations suggest that transcription
of microsatellite repeat-containing RNAs is more sensitive to perturbation than transcription of other RNAs,
indicating potentially viable strategies for therapeutic intervention. In this proposal, we will assess the extent to
which virally delivered dCas9/gRNA complexes can rescue molecular, cellular, and phenotypic features in to
established models of DM1 and C9ALS/FTD. The HSALR model, which exhibits myotonia, centralized nuclei,
and altered transcriptomes characteristic of human DM1, will be used to study DM. The C9-500 BAC
transgenic model, which exhibits upper and lower motor neuron degeneration, altered gait, paralysis, and
premature death, will be used to study C9ALS/FTD. Our proposed experiments will establish whether inhibition
of toxic repeat transcription can rescue disease phenotypes, and define a window around which reduction of
toxic RNA abundance is therapeutic.
扩增的微卫星重复序列的转录与许多人类疾病有关,包括
强直性肌营养不良(DM)、Fuch角膜内皮营养不良和C9 orf 72 ALS/FTD(C9 ALS/FTD),其中
他人消除或减少这些扩增基因座产生的RNA和蛋白质的产生,
治疗益处。在这里,我们将测试一个假设,即Cas9酶的失活形式阻碍了
在DM和C9 ALS/FTD的细胞和动物模型中,我们
先前已经观察到重复序列长度,PAM和链依赖性的重复序列丰度减少,
在将dCas 9直接靶向重复序列后,异常肌盲依赖性剪接
在DM 1细胞中挽救了模式,并且产生C9 orf 72 ALS/FTD细胞特征性的RAN肽
急剧下降。DM 1小鼠模型肌纤维中病理性含CUG的RNA灶,
通过腺相关病毒递送的dCas 9/gRNA减少。这些观察表明,转录
含有微卫星重复序列的RNA的转录比其他RNA的转录对扰动更敏感,
表明潜在可行的治疗干预策略。在本建议中,我们将评估
其中病毒递送的dCas 9/gRNA复合物可以拯救细胞中的分子、细胞和表型特征,
建立了DM 1和C9 ALS/FTD模型。HSALR模型表现出肌强直、核集中,
和人DM 1的改变的转录组特征,将用于研究DM。C9-500 BAC
转基因模型,其表现出上和下运动神经元变性、步态改变、瘫痪,
将用于研究C9 ALS/FTD。我们提出的实验将确定抑制是否
毒性重复转录的减少可以挽救疾病表型,并定义一个窗口,
有毒的RNA丰度是治疗性的。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric T Wang其他文献
Eric T Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric T Wang', 18)}}的其他基金
Impeding transcription of expanded microsatellite repeats using deactivated Cas9
使用失活的 Cas9 阻止扩展微卫星重复序列的转录
- 批准号:
10343730 - 财政年份:2019
- 资助金额:
$ 37.76万 - 项目类别:
Post-transcriptional Regulation of Gene Expression in Neuromuscular Disease
神经肌肉疾病基因表达的转录后调控
- 批准号:
9310806 - 财政年份:2015
- 资助金额:
$ 37.76万 - 项目类别:
Post-transcriptional regulation of gene expression in neuromuscular disease
神经肌肉疾病基因表达的转录后调控
- 批准号:
8608404 - 财政年份:2013
- 资助金额:
$ 37.76万 - 项目类别:
Post-transcriptional regulation of gene expression in neuromuscular disease
神经肌肉疾病基因表达的转录后调控
- 批准号:
8741739 - 财政年份:2013
- 资助金额:
$ 37.76万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 37.76万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 37.76万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 37.76万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 37.76万 - 项目类别:
Fellowship